|
Volumn 20, Issue 1, 2002, Pages 101-104
|
Phase II trial of pegylated-liposomal doxorubicin (Doxil™)in renal cell cancer
|
Author keywords
Cancer; Chemotherapy; Kidney; Liposome; Renal cell cancer
|
Indexed keywords
DOXORUBICIN;
ADULT;
AGED;
ARTICLE;
CARDIOTOXICITY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DOSE RESPONSE;
FEMALE;
HAND FOOT SYNDROME;
HUMAN;
KIDNEY CANCER;
MALE;
MUCOSA INFLAMMATION;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
SKIN TOXICITY;
AGED;
ANTINEOPLASTIC AGENTS;
CARCINOMA, RENAL CELL;
DOXORUBICIN;
FEMALE;
FOOT;
HAND;
HUMANS;
KIDNEY NEOPLASMS;
LIPOSOMES;
MALE;
MIDDLE AGED;
MOUTH MUCOSA;
SKIN DISEASES;
SYNDROME;
|
EID: 0036207829
PISSN: 01676997
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1014428720551 Document Type: Article |
Times cited : (21)
|
References (8)
|